Brivaracetam
CAS No : 357336-20-0
General description:
Brivaracetam is an active pharmaceutical ingredient (API) used as an antiepileptic agent for the treatment of partial-onset seizures in patients with epilepsy. It is a selective high-affinity ligand of synaptic vesicle protein 2A (SV2A), which plays a key role in modulating neurotransmitter release in the central nervous system.
Brivaracetam is manufactured under stringent quality and regulatory standards to ensure high purity, consistent potency, and reliable performance. It is suitable for formulation development, clinical research, and commercial pharmaceutical manufacturing, supporting the production of safe and effective antiepileptic medicines.
Brivaracetam is manufactured under stringent quality and regulatory standards to ensure high purity, consistent potency, and reliable performance. It is suitable for formulation development, clinical research, and commercial pharmaceutical manufacturing, supporting the production of safe and effective antiepileptic medicines.
Chemical Structure:
